MTOR and cancer: The phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) signaling pathway has been proposed as an interesting therapeutic target in cancer with a pivotal role in cell cycle progression, cell proliferation and angiogenesis [15–30].